The Open-label, Proof-of-concept Study of SAGE-547 (Allopregnanolone) in the Treatment of Postpartum Depression

被引：0
|
作者：
Kanes, Stephen J. [1 ]
Colquhoun, Helen [1 ]
Doherty, James [2 ]
Raines, Shane [3 ]
Rubinow, David R. [4 ]
Meltzer-Brody, Samantha [4 ]
机构：
[1] Sage Therapeut, Med Affairs, Cambridge, MA USA
[2] Sage Therapeut, Res & Dev, Cambridge, MA USA
[3] 2b Analyt, Biostat, Wallingford, PA USA
[4] Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA
来源：
BIOLOGICAL PSYCHIATRY | 2016年 / 79卷 / 09期
关键词：
allopregnanolone; postpartum depression; antidepressent;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
339
引用
收藏
页码：133S / 133S
页数：1
相关论文
共 50 条
  • [21] Ustekinumab For The Treatment Of Patients With Active Ankylosing Spondylitis: Results Of a 28-Week, Prospective, Open-Label, Proof-Of-Concept Study (TOPAS)
    Poddubnyy, Denis
    Callhoff, Johanna
    Listing, Joachim
    Sieper, Joachim
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S766 - S766
  • [22] AUTOLOGOUS MESENCHYMAL STEM CELLS FOR THE TREATMENT OF SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS: AN OPEN-LABEL PHASE 2A PROOF-OF-CONCEPT STUDY
    Connick, Peter
    Chandran, Siddharthan
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2013, 84 (11):
  • [23] Treatment for giant cell arteritis with 8 weeks of prednisone in combination with tocilizumab: a single-arm, open-label, proof-of-concept study
    Unizony, Sebastian
    Matza, Mark A.
    Jarvie, Adam
    O'Dea, David
    Fernandes, Ana
    Stone, John H.
    LANCET RHEUMATOLOGY, 2023, 5 (12): : e736 - e742
  • [24] Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study
    Connick, Peter
    Kolappan, Madhan
    Crawley, Charles
    Webber, Daniel J.
    Patani, Rickie
    Michell, Andrew W.
    Du, Ming-Qing
    Luan, Shi-Lu
    Altmann, Daniel R.
    Thompson, Alan J.
    Compston, Alastair
    Scott, Michael A.
    Miller, David H.
    Chandran, Siddharthan
    LANCET NEUROLOGY, 2012, 11 (02): : 150 - 156
  • [25] Natalizumab in progressive MS Results of an open-label, phase 2A, proof-of-concept trial
    Christensen, Jeppe Romme
    Ratzer, Rikke
    Bornsen, Lars
    Lyksborg, Mark
    Garde, Ellen
    Dyrby, Tim B.
    Siebner, Hartwig R.
    Sorensen, Per S.
    Sellebjerg, Finn
    NEUROLOGY, 2014, 82 (17) : 1499 - 1507
  • [26] Rivaroxaban Versus Warfarin in Patients with Mechanical Heart Valves: Open-Label, Proof-of-Concept trial-The RIWA study
    Duraes, Andre Rodrigues
    Lima Bitar, Yasmin de Souza
    Schonhofen, Igor Santos
    Oliveira Travassos, Kethyren Santos
    Pereira, Larissa Vitoria
    Lima Filho, Jose Admirco
    Gomes Neto, Mansueto
    Aras Junior, Roque
    Roever, Leonardo
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2021, 21 (03) : 363 - 371
  • [27] A Phase II Multicentre, Open-Label, Proof-of-Concept Study of Tasquinimod in Hepatocellular, Ovarian, Renal Cell, and Gastric Cancers
    Bernard Escudier
    Sandrine Faivre
    Eric Van Cutsem
    Nathalie Germann
    Jean-Christophe Pouget
    Ruth Plummer
    Ignace Vergote
    Fiona Thistlethwaite
    Georg A. Bjarnason
    Robert Jones
    Helen Mackay
    Julien Edeline
    Laetitia Fartoux
    Hal Hirte
    Amit Oza
    Targeted Oncology, 2017, 12 : 655 - 661
  • [28] A Phase II Multicentre, Open-Label, Proof-of-Concept Study of Tasquinimod in Hepatocellular, Ovarian, Renal Cell, and Gastric Cancers
    Escudier, Bernard
    Faivre, Sandrine
    Van Cutsem, Eric
    Germann, Nathalie
    Pouget, Jean-Christophe
    Plummer, Ruth
    Vergote, Ignace
    Thistlethwaite, Fiona
    Bjarnason, Georg A.
    Jones, Robert
    Mackay, Helen
    Edeline, Julien
    Fartoux, Laetitia
    Hirte, Hal
    Oza, Amit
    TARGETED ONCOLOGY, 2017, 12 (05) : 655 - 661
  • [29] Somatostatin analogues as second-line treatment in adult patients with recurrent medulloblastoma: A case report and a concept for a multicentric, open-label, proof-of-concept, phase I study
    Glas, M.
    Hirschmann, B.
    Steinbrecher, A.
    Hau, P.
    Bogdahn, U.
    NEURO-ONCOLOGY, 2006, 8 (04) : 341 - 341
  • [30] A Pilot, Open-Label, Proof-of-Concept Study To Evaluate the Efficacy and Safety of Asthiposhak® Tablets in Participants Suffering From Asthikshaya or Osteopenia
    Kumar, Khushal
    Godatwar, Pawankumar
    Sharma, Sanjeev
    Narvekar, Sangam
    Nalawade, Megha
    Chawda, Mukesh B.
    Verma, Pragya
    Seetharaman, Rajmohan
    Tripathi, Raakhi K.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (07)
12345